Nature of Disclosure: Regulatory compliance disclosure under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulation 30(5).
Board Approval: The Board of Directors of Wardwizard Healthcare Limited approved the revision in authorities for determining materiality of events and making disclosures to stock exchanges at its meeting held on May 30, 2026.
Effective Date: The revision becomes effective from May 30, 2026.
Authority Structure: The revised authorities allow Key Managerial Personnel to determine materiality of events either jointly and/or severally and to make appropriate disclosures/submissions to stock exchanges.
Authorized Key Managerial Personnel:
- Mr. Gaurav Jayant Gupte, Managing Director (Contact: ayokimerchantile@gmail.com)
- Mr. Yuvraj Priyadarshi, CEO cum Director (Contact: dr.yuvraj@wardwizardmed.com)
- Ms. Harshita Kharva, Chief Financial Officer (Contact: ayokiacc@gmail.com)
- Ms. Rajbala Kiroriwal, Company Secretary and Compliance Officer (Contact: ayoki1985@gmail.com)
Regulatory Reference: This disclosure is made pursuant to Regulation 30 and all other applicable Regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.
Previous Communication: Reference is made to an earlier letter dated November 14, 2025, which previously intimated the name of Key Managerial Personnel for determining materiality under Regulation 30(5).
Additional Information: The details of the authorized personnel are available on the Company's website at https://www.ayokimerchantile.com